Follow
Angelo Maiolino, MD, PhD
Angelo Maiolino, MD, PhD
Verified email at hucff.ufrj.br
Title
Cited by
Cited by
Year
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
10072012
Fusarium Infection in Hematopoietic Stem Cell Transplant Recipients
M Nucci, KA Marr, F Queiroz-Telles, CA Martins, P Trabasso, S Costa, ...
Clinical Infectious Diseases 38 (9), 1237-1242, 2004
3662004
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
M Nucci, EJ Anaissie, F Queiroz‐Telles, CA Martins, P Trabasso, C Solza, ...
Cancer 98 (2), 315-319, 2003
3552003
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
P Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ...
The Lancet 397 (10292), 2361-2371, 2021
2722021
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ...
The Lancet 393 (10168), 253-264, 2019
2442019
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
AL Oliveira, M De Souza, VMH Carvalho-Dias, MA Ruiz, L Silla, ...
Bone marrow transplantation 39 (12), 775-781, 2007
2352007
Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria
A Maiolino, I Biasoli, J Lima, AC Portugal, W Pulcheri, M Nucci
Bone marrow transplantation 31 (5), 393-397, 2003
2022003
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
P Moreau, SK Kumar, J San Miguel, F Davies, E Zamagni, N Bahlis, ...
The Lancet Oncology 22 (3), e105-e118, 2021
1982021
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry
RJP de Magalhães, MB Vidriales, B Paiva, C Fernandez-Gimenez, ...
Haematologica 98 (1), 79, 2013
1702013
Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection
LMB da Fonseca, B Gutfilen, PHR de Castro, V Battistella, ...
Experimental neurology 221 (1), 122-128, 2010
1702010
A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory …
RZ Orlowski, L Gercheva, C Williams, H Sutherland, T Robak, T Masszi, ...
American journal of hematology 90 (1), 42-49, 2015
1552015
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program
JR Mikhael, AR Belch, HM Prince, MN Lucio, A Maiolino, A Corso, ...
British journal of haematology 144 (2), 169-175, 2009
1372009
Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients
PH Rosado-de-Castro, FR Schmidt, V Battistella, SA Lopes de Souza, ...
Regenerative medicine 8 (2), 145-155, 2013
1232013
Salvage second hematopoietic cell transplantation in myeloma
LC Michaelis, A Saad, X Zhong, J Le-Rademacher, CO Freytes, DI Marks, ...
Biology of Blood and Marrow Transplantation 19 (5), 760-766, 2013
1212013
Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation
SC Maradei, A Maiolino, AM de Azevedo, M Colares, LF Bouzas, M Nucci
Blood, The Journal of the American Society of Hematology 114 (6), 1270-1275, 2009
1172009
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis
S Kumar, MJ Zhang, P Li, A Dispenzieri, GA Milone, S Lonial, A Krishnan, ...
Blood, The Journal of the American Society of Hematology 118 (7), 1979-1988, 2011
952011
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
LJ Costa, BA Derman, S Bal, S Sidana, S Chhabra, R Silbermann, JC Ye, ...
Leukemia 35 (1), 18-30, 2021
892021
Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy
L Sanoja-Flores, J Flores-Montero, N Puig, T Contreras-Sanfeliciano, ...
Blood, The Journal of the American Society of Hematology 134 (24), 2218-2222, 2019
882019
Older patients with myeloma derive similar benefit from autologous transplantation
M Sharma, MJ Zhang, X Zhong, MH Abidi, G Akpek, U Bacher, ...
Biology of Blood and Marrow Transplantation 20 (11), 1796-1803, 2014
862014
Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study
BG Couto, RCS Goldenberg, LMB da Fonseca, J Thomas, B Gutfilen, ...
Liver International 31 (3), 391-400, 2011
842011
The system can't perform the operation now. Try again later.
Articles 1–20